These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 39379032

  • 1. Exploring correlations between Conners' Continuous Performance Test and subjective measures of attention deficit hyperactivity disorder symptoms in a paediatric clinical sample.
    Poh XWW, Lim SSY, Chew YY, Lim-Ashworth NSJ, Lim CG.
    Singapore Med J; 2024 Oct 01; 65(10):558-563. PubMed ID: 39379032
    [Abstract] [Full Text] [Related]

  • 2. Is the Conners' continuous performance test helpful for assessing attention deficit hyperactivity disorder in a clinical setting?
    Johnsen KH, Kvitland LR, Sollie H, Reiestad M, Jonsbu E, Hagen K, Weidle B.
    Nord J Psychiatry; 2024 Feb 01; 78(2):120-127. PubMed ID: 37971369
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of Neuropsychiatric Function in Phenylketonuria: Psychometric Properties of the ADHD Rating Scale-IV and Adult ADHD Self-Report Scale Inattention Subscale in Phenylketonuria.
    Wyrwich KW, Auguste P, Yu R, Zhang C, Dewees B, Winslow B, Yu S, Merilainen M, Prasad S.
    Value Health; 2015 Jun 01; 18(4):404-12. PubMed ID: 26091594
    [Abstract] [Full Text] [Related]

  • 4. Validation of the French Version of Conners' Parent Rating Scale-Revised, Short Form in ADHD-Diagnosed Children and Comparison With Control Children.
    Fumeaux P, Mercier C, Roche S, Iwaz J, Stéphan P, Revol O.
    J Atten Disord; 2021 Jan 01; 25(1):124-133. PubMed ID: 29562852
    [Abstract] [Full Text] [Related]

  • 5. Self-inserted foreign body and attention-deficit/hyperactivity disorder: evaluated by the Conners' Parent Rating Scales-Revised.
    Özcan K, Özcan Ö, Muluk NB, Cingi C, Durukan K.
    Int J Pediatr Otorhinolaryngol; 2013 Dec 01; 77(12):1992-7. PubMed ID: 24139587
    [Abstract] [Full Text] [Related]

  • 6. A randomised controlled trial of the Neuro Emotional Technique (NET) for childhood Attention Deficit Hyperactivity Disorder (ADHD): a protocol.
    Karpouzis F, Pollard H, Bonello R.
    Trials; 2009 Jan 27; 10():6. PubMed ID: 19173743
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness and cost-effectiveness of a brief school-based group programme for parents of children at risk of ADHD: a cluster randomised controlled trial.
    Sayal K, Taylor JA, Valentine A, Guo B, Sampson CJ, Sellman E, James M, Hollis C, Daley D.
    Child Care Health Dev; 2016 Jul 27; 42(4):521-33. PubMed ID: 27272608
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic Accuracy of Rating Scales for Attention-Deficit/Hyperactivity Disorder: A Meta-analysis.
    Chang LY, Wang MY, Tsai PS.
    Pediatrics; 2016 Mar 27; 137(3):e20152749. PubMed ID: 26928969
    [Abstract] [Full Text] [Related]

  • 9. Conners' continuous performance test (CCPT-II) in children with ADHD, ODD, or a combined ADHD/ODD diagnosis.
    Munkvold LH, Manger T, Lundervold AJ.
    Child Neuropsychol; 2014 Mar 27; 20(1):106-26. PubMed ID: 23244393
    [Abstract] [Full Text] [Related]

  • 10. ROC Analyses of Relevant Conners 3-Short Forms, CBCL, and TRF Scales for Screening ADHD and ODD.
    Gomez R, Vance A, Watson S, Stavropoulos V.
    Assessment; 2021 Jan 27; 28(1):73-85. PubMed ID: 31535569
    [Abstract] [Full Text] [Related]

  • 11. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].
    Dereboy C, Senol S, Sener S, Dereboy F.
    Turk Psikiyatri Derg; 2007 Jan 27; 18(1):48-58. PubMed ID: 17364268
    [Abstract] [Full Text] [Related]

  • 12. Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul.
    Arman AR, Ersu R, Save D, Karadag B, Karaman G, Karabekiroglu K, Karakoc F, Dagli E, Berkem M.
    Child Care Health Dev; 2005 Nov 27; 31(6):707-17. PubMed ID: 16207229
    [Abstract] [Full Text] [Related]

  • 13. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P, Shalev L, Tsamir D, Manor I, Weizman A.
    Int Clin Psychopharmacol; 2019 May 27; 34(3):138-142. PubMed ID: 30640748
    [Abstract] [Full Text] [Related]

  • 14. Parent-reported executive function behaviors and clinician ratings of attention-deficit/hyperactivity disorder symptoms in children treated with lisdexamfetamine dimesylate.
    Findling RL, Adeyi B, Dirks B, Babcock T, Scheckner B, Lasser R, DeLeon A, Ginsberg LD.
    J Child Adolesc Psychopharmacol; 2013 Feb 27; 23(1):28-35. PubMed ID: 23410139
    [Abstract] [Full Text] [Related]

  • 15. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D, Jarman F, Barker M.
    Pediatrics; 1997 Dec 27; 100(6):E6. PubMed ID: 9382907
    [Abstract] [Full Text] [Related]

  • 16. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW, Earl CQ, Arora S.
    Curr Med Res Opin; 2006 Dec 27; 22(12):2457-65. PubMed ID: 17257460
    [Abstract] [Full Text] [Related]

  • 17. High Attention-Deficit/Hyperactivity Disorder Scale Scores Among Patients with Persistent Chronic Nonspecific Low Back Pain.
    Kasahara S, Niwa SI, Matsudaira K, Sato N, Oka H, Fujii T, Konno SI, Kikuchi SI, Yamada Y.
    Pain Physician; 2021 May 27; 24(3):E299-E307. PubMed ID: 33988951
    [Abstract] [Full Text] [Related]

  • 18. Psychometric properties of two ADHD questionnaires: comparing the Conners' scale and the FBB-HKS in the general population of German children and adolescents--results of the BELLA study.
    Erhart M, Döpfner M, Ravens-Sieberer U, BELLA study group.
    Eur Child Adolesc Psychiatry; 2008 Dec 27; 17 Suppl 1():106-15. PubMed ID: 19132310
    [Abstract] [Full Text] [Related]

  • 19. The Groundskeeper Gaming Platform as a Diagnostic Tool for Attention-Deficit/Hyperactivity Disorder: Sensitivity, Specificity, and Relation to Other Measures.
    Faraone SV, Newcorn JH, Antshel KM, Adler L, Roots K, Heller M.
    J Child Adolesc Psychopharmacol; 2016 Oct 27; 26(8):672-685. PubMed ID: 27105181
    [Abstract] [Full Text] [Related]

  • 20. Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
    Jain R, Segal S, Kollins SH, Khayrallah M.
    J Am Acad Child Adolesc Psychiatry; 2011 Feb 27; 50(2):171-9. PubMed ID: 21241954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.